HEADER TRANSFERASE/INHIBITOR 21-SEP-23 8UAK TITLE CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PKC ALPHA (D463N, TITLE 2 V568I, S657E) IN COMPLEX WITH DAROVASERTIB (NVP-LXS196) AT 2.82-A TITLE 3 RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN KINASE C ALPHA TYPE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 320-672; COMPND 5 SYNONYM: PKC-A,PKC-ALPHA; COMPND 6 EC: 2.7.11.13; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PRKCA, PKCA, PRKACA; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS INHIBITOR, COMPLEX, DAROVASERTIB, NVP-LXS196, NVP-CJL037, 8U37, KEYWDS 2 TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.J.ROMANOWSKI,J.LAM,M.VISSER REVDAT 3 13-NOV-24 8UAK 1 REMARK REVDAT 2 31-JAN-24 8UAK 1 JRNL REVDAT 1 24-JAN-24 8UAK 0 JRNL AUTH M.VISSER,J.P.N.PAPILLON,M.LUZZIO,M.J.LAMARCHE,J.FAN, JRNL AUTH 2 W.MICHAEL,D.WANG,A.ZHANG,C.STRAUB,S.MATHIEU,M.KATO, JRNL AUTH 3 M.PALERMO,C.CHEN,T.RAMSEY,C.JOUD,R.BARRETT,A.VATTAY,R.GUO, JRNL AUTH 4 A.BRIC,F.CHUNG,G.LIANG,M.J.ROMANOWSKI,J.LAM,S.THOHAN, JRNL AUTH 5 F.ATASSI,A.WYLIE,V.G.COOKE JRNL TITL DISCOVERY OF DAROVASERTIB (NVP-LXS196), A PAN-PKC INHIBITOR JRNL TITL 2 FOR THE TREATMENT OF METASTATIC UVEAL MELANOMA. JRNL REF J.MED.CHEM. V. 67 1447 2024 JRNL REFN ISSN 0022-2623 JRNL PMID 38198520 JRNL DOI 10.1021/ACS.JMEDCHEM.3C02002 REMARK 2 REMARK 2 RESOLUTION. 2.82 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.82 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.67 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 9281 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.730 REMARK 3 FREE R VALUE TEST SET COUNT : 439 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.6700 - 4.0700 0.99 3005 139 0.1800 0.2150 REMARK 3 2 4.0700 - 3.2300 0.99 2910 160 0.2278 0.2687 REMARK 3 3 3.2300 - 2.8200 1.00 2927 140 0.2970 0.3412 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.352 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.233 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 81.66 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 100.1 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2713 REMARK 3 ANGLE : 1.339 3675 REMARK 3 CHIRALITY : 0.080 388 REMARK 3 PLANARITY : 0.009 470 REMARK 3 DIHEDRAL : 8.610 363 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 24.5258 -1.3768 16.8209 REMARK 3 T TENSOR REMARK 3 T11: 0.5229 T22: 0.5025 REMARK 3 T33: 0.5230 T12: -0.0720 REMARK 3 T13: -0.0750 T23: 0.0397 REMARK 3 L TENSOR REMARK 3 L11: 2.0085 L22: 2.8174 REMARK 3 L33: 3.8483 L12: 0.1280 REMARK 3 L13: -1.1280 L23: -0.6633 REMARK 3 S TENSOR REMARK 3 S11: 0.1117 S12: -0.2115 S13: 0.0245 REMARK 3 S21: 0.5228 S22: -0.2031 S23: 0.0810 REMARK 3 S31: -0.3600 S32: 0.2577 S33: -0.0089 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8UAK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-SEP-23. REMARK 100 THE DEPOSITION ID IS D_1000277702. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-DEC-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 200K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9293 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.820 REMARK 200 RESOLUTION RANGE LOW (A) : 53.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.82 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.83 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.62800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3IW4 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 21 MG/ML PROTEIN IN 50 MM IMIDAZOLE, REMARK 280 200 MM SODIUM CHLORIDE, 2 MM TCEP, 1 MM NAF, 1% GLYCEROL, PH 8.0 REMARK 280 AGAINST 0.1 M BIS-TRIS, PH 5.5, 18% PEG3350, 0.2 M MAGNESIUM REMARK 280 CHLORIDE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 54.90900 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 22.26600 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 54.90900 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 22.26600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 319 REMARK 465 PRO A 320 REMARK 465 SER A 321 REMARK 465 GLU A 322 REMARK 465 ASP A 323 REMARK 465 ARG A 324 REMARK 465 LYS A 325 REMARK 465 GLN A 326 REMARK 465 PRO A 327 REMARK 465 SER A 328 REMARK 465 ASN A 329 REMARK 465 ASN A 330 REMARK 465 LEU A 331 REMARK 465 CYS A 619 REMARK 465 GLY A 620 REMARK 465 LYS A 621 REMARK 465 GLY A 622 REMARK 465 ALA A 623 REMARK 465 GLU A 624 REMARK 465 ASN A 625 REMARK 465 PHE A 626 REMARK 465 ASP A 627 REMARK 465 LYS A 628 REMARK 465 PHE A 629 REMARK 465 PHE A 630 REMARK 465 THR A 631 REMARK 465 ARG A 632 REMARK 465 GLY A 633 REMARK 465 GLN A 634 REMARK 465 ILE A 667 REMARK 465 LEU A 668 REMARK 465 GLN A 669 REMARK 465 SER A 670 REMARK 465 ALA A 671 REMARK 465 VAL A 672 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 363 OH TYR A 365 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 481 85.43 72.21 REMARK 500 MET A 573 30.30 -99.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8U37 RELATED DB: PDB REMARK 900 NVP-CJL037 DBREF 8UAK A 320 672 UNP P17252 KPCA_HUMAN 320 672 SEQADV 8UAK GLY A 319 UNP P17252 EXPRESSION TAG SEQADV 8UAK ASN A 463 UNP P17252 ASP 463 ENGINEERED MUTATION SEQADV 8UAK ILE A 568 UNP P17252 VAL 568 ENGINEERED MUTATION SEQADV 8UAK GLU A 657 UNP P17252 SER 657 ENGINEERED MUTATION SEQRES 1 A 354 GLY PRO SER GLU ASP ARG LYS GLN PRO SER ASN ASN LEU SEQRES 2 A 354 ASP ARG VAL LYS LEU THR ASP PHE ASN PHE LEU MET VAL SEQRES 3 A 354 LEU GLY LYS GLY SER PHE GLY LYS VAL MET LEU ALA ASP SEQRES 4 A 354 ARG LYS GLY THR GLU GLU LEU TYR ALA ILE LYS ILE LEU SEQRES 5 A 354 LYS LYS ASP VAL VAL ILE GLN ASP ASP ASP VAL GLU CYS SEQRES 6 A 354 THR MET VAL GLU LYS ARG VAL LEU ALA LEU LEU ASP LYS SEQRES 7 A 354 PRO PRO PHE LEU THR GLN LEU HIS SER CYS PHE GLN THR SEQRES 8 A 354 VAL ASP ARG LEU TYR PHE VAL MET GLU TYR VAL ASN GLY SEQRES 9 A 354 GLY ASP LEU MET TYR HIS ILE GLN GLN VAL GLY LYS PHE SEQRES 10 A 354 LYS GLU PRO GLN ALA VAL PHE TYR ALA ALA GLU ILE SER SEQRES 11 A 354 ILE GLY LEU PHE PHE LEU HIS LYS ARG GLY ILE ILE TYR SEQRES 12 A 354 ARG ASN LEU LYS LEU ASP ASN VAL MET LEU ASP SER GLU SEQRES 13 A 354 GLY HIS ILE LYS ILE ALA ASP PHE GLY MET CYS LYS GLU SEQRES 14 A 354 HIS MET MET ASP GLY VAL THR THR ARG TPO PHE CYS GLY SEQRES 15 A 354 THR PRO ASP TYR ILE ALA PRO GLU ILE ILE ALA TYR GLN SEQRES 16 A 354 PRO TYR GLY LYS SER VAL ASP TRP TRP ALA TYR GLY VAL SEQRES 17 A 354 LEU LEU TYR GLU MET LEU ALA GLY GLN PRO PRO PHE ASP SEQRES 18 A 354 GLY GLU ASP GLU ASP GLU LEU PHE GLN SER ILE MET GLU SEQRES 19 A 354 HIS ASN VAL SER TYR PRO LYS SER LEU SER LYS GLU ALA SEQRES 20 A 354 VAL SER ILE CYS LYS GLY LEU MET THR LYS HIS PRO ALA SEQRES 21 A 354 LYS ARG LEU GLY CYS GLY PRO GLU GLY GLU ARG ASP VAL SEQRES 22 A 354 ARG GLU HIS ALA PHE PHE ARG ARG ILE ASP TRP GLU LYS SEQRES 23 A 354 LEU GLU ASN ARG GLU ILE GLN PRO PRO PHE LYS PRO LYS SEQRES 24 A 354 VAL CYS GLY LYS GLY ALA GLU ASN PHE ASP LYS PHE PHE SEQRES 25 A 354 THR ARG GLY GLN PRO VAL LEU TPO PRO PRO ASP GLN LEU SEQRES 26 A 354 VAL ILE ALA ASN ILE ASP GLN SER ASP PHE GLU GLY PHE SEQRES 27 A 354 GLU TYR VAL ASN PRO GLN PHE VAL HIS PRO ILE LEU GLN SEQRES 28 A 354 SER ALA VAL MODRES 8UAK TPO A 497 THR MODIFIED RESIDUE MODRES 8UAK TPO A 638 THR MODIFIED RESIDUE HET TPO A 497 11 HET TPO A 638 11 HET W39 A 701 34 HETNAM TPO PHOSPHOTHREONINE HETNAM W39 (6M)-3-AMINO-N-[3-(4-AMINO-4-METHYLPIPERIDIN-1-YL) HETNAM 2 W39 PYRIDIN-2-YL]-6-[3-(TRIFLUOROMETHYL)PYRIDIN-2- HETNAM 3 W39 YL]PYRAZINE-2-CARBOXAMIDE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 2 W39 C22 H23 F3 N8 O FORMUL 3 HOH *(H2 O) HELIX 1 AA1 LYS A 335 THR A 337 5 3 HELIX 2 AA2 LYS A 372 ASP A 378 1 7 HELIX 3 AA3 ASP A 380 ALA A 392 1 13 HELIX 4 AA4 ASP A 424 GLY A 433 1 10 HELIX 5 AA5 LYS A 436 ARG A 457 1 22 HELIX 6 AA6 LYS A 465 ASP A 467 5 3 HELIX 7 AA7 THR A 501 ILE A 505 5 5 HELIX 8 AA8 ALA A 506 ALA A 511 1 6 HELIX 9 AA9 LYS A 517 GLY A 534 1 18 HELIX 10 AB1 ASP A 542 HIS A 553 1 12 HELIX 11 AB2 SER A 562 MET A 573 1 12 HELIX 12 AB3 HIS A 576 ARG A 580 5 5 HELIX 13 AB4 GLU A 586 GLU A 593 1 8 HELIX 14 AB5 HIS A 594 ARG A 598 5 5 HELIX 15 AB6 ASP A 601 ASN A 607 1 7 HELIX 16 AB7 ASP A 641 ALA A 646 1 6 HELIX 17 AB8 ASN A 647 ILE A 648 5 2 HELIX 18 AB9 ASP A 649 GLU A 654 5 6 SHEET 1 AA1 6 PHE A 339 GLY A 348 0 SHEET 2 AA1 6 GLY A 351 ARG A 358 -1 O LEU A 355 N MET A 343 SHEET 3 AA1 6 LEU A 364 LYS A 371 -1 O ILE A 369 N LYS A 352 SHEET 4 AA1 6 ARG A 412 GLU A 418 -1 O LEU A 413 N LEU A 370 SHEET 5 AA1 6 LEU A 403 GLN A 408 -1 N HIS A 404 O VAL A 416 SHEET 6 AA1 6 TYR A 658 VAL A 659 -1 O TYR A 658 N CYS A 406 SHEET 1 AA2 2 VAL A 469 LEU A 471 0 SHEET 2 AA2 2 ILE A 477 ILE A 479 -1 O LYS A 478 N MET A 470 LINK C ARG A 496 N TPO A 497 1555 1555 1.33 LINK C TPO A 497 N PHE A 498 1555 1555 1.33 LINK C LEU A 637 N TPO A 638 1555 1555 1.33 LINK C TPO A 638 N PRO A 639 1555 1555 1.36 CRYST1 109.818 44.532 85.691 90.00 114.04 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009106 0.000000 0.004062 0.00000 SCALE2 0.000000 0.022456 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012778 0.00000